Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bryne

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Urology|July 1, 1997
Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2T Jørgensen, Y Kanagasingam, O Kaalhus, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 5, 2001
Prognostic value of graph theory-based tissue architecture analysis in carcinomas of the tongueJ Sudbø, A Bankfalvi, M Bryne, et al.
Head & Neck|February 17, 1998
Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomasJ Piffkò, A Bànkfalvi, K Tory, et al.
Gynecologic Oncology|December 6, 2000
E-Cadherin complex protein expression and survival in ovarian carcinomaB Davidson, W H Gotlieb, G Ben-Baruch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinomaI Goldberg, B Davidson, R Reich, et al.
Gynecologic Oncology|March 31, 2000
Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic studyB Davidson, W H Gotlieb, G Ben-Baruch, et al.
The American Journal of Surgical Pathology|November 22, 2001
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcomeB Davidson, B Risberg, I Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinomaB Davidson, R Reich, I Goldberg, et al.
Clinical & Experimental Metastasis|November 23, 2000
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinomaB Davidson, I Goldberg, W H Gotlieb, et al.
Gynecologic Oncology|May 2, 2001
Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic studyB Davidson, J M Nesland, I Goldberg, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Urology|July 1, 1997
Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2T Jørgensen, Y Kanagasingam, O Kaalhus, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 5, 2001
Prognostic value of graph theory-based tissue architecture analysis in carcinomas of the tongueJ Sudbø, A Bankfalvi, M Bryne, et al.
Head & Neck|February 17, 1998
Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomasJ Piffkò, A Bànkfalvi, K Tory, et al.
Gynecologic Oncology|December 6, 2000
E-Cadherin complex protein expression and survival in ovarian carcinomaB Davidson, W H Gotlieb, G Ben-Baruch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinomaI Goldberg, B Davidson, R Reich, et al.
Gynecologic Oncology|March 31, 2000
Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic studyB Davidson, W H Gotlieb, G Ben-Baruch, et al.
The American Journal of Surgical Pathology|November 22, 2001
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcomeB Davidson, B Risberg, I Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinomaB Davidson, R Reich, I Goldberg, et al.
Clinical & Experimental Metastasis|November 23, 2000
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinomaB Davidson, I Goldberg, W H Gotlieb, et al.
Gynecologic Oncology|May 2, 2001
Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic studyB Davidson, J M Nesland, I Goldberg, et al.
Pageof 6